EPISCREEN Trademark

Trademark Overview


On Thursday, August 6, 2015, a trademark application was filed for EPISCREEN with the United States Patent and Trademark Office. The USPTO has given the EPISCREEN trademark a serial number of 86716415. The federal status of this trademark filing is PARTIAL SECTION 8 ACCEPTED as of Saturday, September 30, 2023. This trademark is owned by Polytherics Limited. The EPISCREEN trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Medical services, namely, providing medical information regarding pharmaceuticals; Pharmacy and health advice; pharmaceutical services and provision of pharmaceutical information, all in the nature of providing medical information regarding pharmaceuticals; Medical screening; Medical screening to assess the potential immunogenicity of therapeutic antibodies and proteins

[ Pharmaceuticals and pharmaceutical preparations used to treat cancer, diseases and disorders of the immune system, viral diseases and disorders, inflammatory diseases, fibrotic diseases, pulmonary diseases, gastro-intestinal diseases and disorders, haematological diseases and disorders, neurological diseases and disorders, pain, obesity, diabetes and graft rejection; chemical preparations for medical or pharmaceutical purposes, namely, chemicals sold as integral component parts of pharmaceutical preparations for the treatment of cancer, diseases and disorders of the immune system, viral diseases and disorders, inflammatory diseases, fibrotic diseases, pulmonary diseases, gastro-intestinal diseases and disorders, haematological diseases and disorders, neurological diseases and disorders, pain, obesity, diabetes and graft rejection; chemico-pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of cancer, diseases and disorders of the immune system, viral di...

Scientific research and product development services in relation to pharmaceutical and medical products; pharmaceutical research services; pharmaceutical product evaluation; testing of pharmaceuticals, namely, assessing the potential immunogenicity of proteins and antibodies by measuring immune cell responses to the pharmaceutical; pharmaceutical drug development services; development of pharmaceutical preparations and medicines; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; provision of scientific information in the fields of cancer, diseases and disorders of the immune system, viral diseases and disorders, inflammatory diseases, fibrotic diseases, pulmonary diseases, gastro-intestinal diseases and disorders, haematological diseases and disorders, neurological diseases and disorders, pain, obesity, diabetes and graft rejection; toxicology services; provision of scientific information relating to the chemical industry, namely...
episcreen

General Information


Serial Number86716415
Word MarkEPISCREEN
Filing DateThursday, August 6, 2015
Status704 - PARTIAL SECTION 8 ACCEPTED
Status DateSaturday, September 30, 2023
Registration Number5093688
Registration DateTuesday, December 6, 2016
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 28, 2016

Trademark Statements


Goods and ServicesMedical services, namely, providing medical information regarding pharmaceuticals; Pharmacy and health advice; pharmaceutical services and provision of pharmaceutical information, all in the nature of providing medical information regarding pharmaceuticals; Medical screening; Medical screening to assess the potential immunogenicity of therapeutic antibodies and proteins
Goods and Services[ Pharmaceuticals and pharmaceutical preparations used to treat cancer, diseases and disorders of the immune system, viral diseases and disorders, inflammatory diseases, fibrotic diseases, pulmonary diseases, gastro-intestinal diseases and disorders, haematological diseases and disorders, neurological diseases and disorders, pain, obesity, diabetes and graft rejection; chemical preparations for medical or pharmaceutical purposes, namely, chemicals sold as integral component parts of pharmaceutical preparations for the treatment of cancer, diseases and disorders of the immune system, viral diseases and disorders, inflammatory diseases, fibrotic diseases, pulmonary diseases, gastro-intestinal diseases and disorders, haematological diseases and disorders, neurological diseases and disorders, pain, obesity, diabetes and graft rejection; chemico-pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of cancer, diseases and disorders of the immune system, viral diseases and disorders, inflammatory diseases, fibrotic diseases, pulmonary diseases, gastro-intestinal diseases and disorders, haematological diseases and disorders, neurological diseases and disorders, pain, obesity, diabetes and graft rejection; vaccines; pharmaceutical preparations for skin care ]
Goods and ServicesScientific research and product development services in relation to pharmaceutical and medical products; pharmaceutical research services; pharmaceutical product evaluation; testing of pharmaceuticals, namely, assessing the potential immunogenicity of proteins and antibodies by measuring immune cell responses to the pharmaceutical; pharmaceutical drug development services; development of pharmaceutical preparations and medicines; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; provision of scientific information in the fields of cancer, diseases and disorders of the immune system, viral diseases and disorders, inflammatory diseases, fibrotic diseases, pulmonary diseases, gastro-intestinal diseases and disorders, haematological diseases and disorders, neurological diseases and disorders, pain, obesity, diabetes and graft rejection; toxicology services; provision of scientific information relating to the chemical industry, namely, information on the subject of chemical product development

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status CodeB - Sec. 8 - Class(es) in a Multiple Class registration
Class Status DateSaturday, September 30, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, August 11, 2015
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, August 11, 2015
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameABZENA (UK) LIMITED
Party Type31 - New Owner After Registration
Legal Entity Type24 - NOT AVAILABLE
AddressCAMBRIDGE CB22 3AT
GB

Party NamePolytherics Limited
Party Type30 - Original Registrant
Legal Entity Type11 - Company
AddressCambridge CB223AT
GB

Party NamePolytherics Limited
Party Type20 - Owner at Publication
Legal Entity Type11 - Company
AddressCambridge CB223AT
GB

Party NamePolytherics Limited
Party Type10 - Original Applicant
Legal Entity Type11 - Company
AddressCambridge CB223AT
GB

Trademark Events


Event DateEvent Description
Monday, August 10, 2015NEW APPLICATION ENTERED
Tuesday, August 11, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, November 18, 2015ASSIGNED TO EXAMINER
Thursday, November 19, 2015NON-FINAL ACTION WRITTEN
Thursday, November 19, 2015NON-FINAL ACTION E-MAILED
Thursday, November 19, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, April 15, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, April 28, 2016ASSIGNED TO LIE
Thursday, May 5, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 5, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 13, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, May 20, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, June 8, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 28, 2016PUBLISHED FOR OPPOSITION
Tuesday, June 28, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 23, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 11, 2016TEAS POST PUBLICATION AMENDMENT RECEIVED
Sunday, October 30, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, October 11, 2016NOTICE OF ALLOWANCE CANCELLED
Monday, October 31, 20161(B) BASIS DELETED; PROCEED TO REGISTRATION
Tuesday, December 6, 2016REGISTERED-PRINCIPAL REGISTER
Wednesday, July 31, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, December 6, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, December 2, 2022TEAS SECTION 8 RECEIVED
Friday, June 2, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, June 2, 2023POST REGISTRATION ACTION MAILED - SEC. 8
Friday, September 22, 2023TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Saturday, September 30, 2023REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED
Saturday, September 30, 2023NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Saturday, December 6, 2025COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED